Gregory T. Went, Chief Executive Officer at Adamas Pharmaceuticals Inc (ADMS), sold 2,807 shares at $17.03 ($48K) on 2017-03-21, disclosed to the SEC on 2017-03-22.
Open-market sale of $48k ADMS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADMS | SELL | 2018-03-22 | $234K | — | Filing → |
| ADMS | SELL | 2015-05-14 | $49K | — | Filing → |
| ADMS | SELL | 2015-04-27 | $59K | — | Filing → |